Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 May;128(2):302-7.
doi: 10.1046/j.1365-2249.2002.01853.x.

Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS)

G R D Batstone  1 , A Doble, J S H Gaston
Affiliations

Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS)

G R D Batstone et al. Clin Exp Immunol. 2002 May.

Abstract

The aetiology of chronic prostatitis is not understood. The aim of this study is to investigate an autoimmune hypothesis by looking for T cell proliferation in response to proteins of the seminal plasma. We studied peripheral blood mononuclear cell proliferation from 20 patients with chronic prostatitis and 20 aged-matched controls in response to serial dilutions of seminal plasma (SP) from themselves (autologous SP) and from a healthy individual without the disease (allo-SP). We found that the patients have a statistically greater lymphocyte proliferation to autologous SP at the 1/50 dilution on day 6 compared to controls (P = 0 x 01). They also have a greater proliferation to allo-SP on both day 5 (P = 0 x 001) and day 6 (P = 0 x 01) at the same dilution. Using a stimulation index (SI) of 9 to either autologous SP or allo-SP on day 6 at the 1/50 dilution as a definition of a proliferative response to SP, then 13/20 patients as compared to 3/20 controls showed a proliferative response to SP (P = 0 x 003, Fishers exact test). These data support an autoimmune hypothesis for chronic prostatitis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mean proliferative responses of PBMC from 20 patients and 20 controls to different concentrations of autologous SP (1/25–1/200). Results are expressed as SI (±s.e.m.) on day 6. ▴, Patients; •, controls.
Fig. 2
Fig. 2
Proliferative responses of PBMC from patients and controls to the antigens 1000 units/ml PPD (a) and 100 μg/ml KLH (b). Results are expressed as the mean SI on days 5–9 of culture. ▴, Patients; •, controls.
Fig. 3
Fig. 3
Proliferative responses of PBMC from an individual patient to unfractionated autologous and allogeneic SP, and to fractions of autologous SP produced by ultracentrifugation (i.e. prostasomes and supernatant). Results are expressed as 3H]-thymidine incorporation mean c.p.m. (±s.e.m.). ○, Control: no antigen; ▪, autologous SP 1/50; ♦, allo-SP 1/50; •, autologous SP 100 000g supernatant; ×, autologous prostasomes 1/12·5.
See this image and copyright information in PMC

References

    1. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Workshop on Chronic Prostatitis: Summary Statement. Bethseda, MD: United States Department of Health and Human Services; 1995. December.
    1. Collins MM, O’Leary MP, Barry MJ. Prevalence of bothersome genitourinary symptoms and diagnoses in younger men on routine primary care visits. Urology. 1998;52:422–7. - PubMed
    1. Collins MM, Stafford RS, O’Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159:1224–8. - PubMed
    1. Wenniger K, Heiman JR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol. 1996;155:965–8. - PubMed
    1. Krieger JN, Riley DE, Roberts MC, Berger RE. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol. 1996;34:3120–8. - PMC - PubMed

Publication types